Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the RELIEF Study

References

• Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11(1):770. doi:10.1186/1471-2458-11-770
   PubMed Web of Science ®Google Scholar
• Harker J, Reid KJ, Bekkering GE, et al. Epidemiology of chronic pain in Denmark and Sweden. Pain Res Treat. 2012;2012:371248.
   PubMedGoogle Scholar
• Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin. 2011;27(2):463–480. doi:10.1185/03007995.2010.542136
   PubMed Web of Science ®Google Scholar
• Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55–64. doi:10.1097/j.pain.0000000000000314
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Stingl JC. Prevalence and comorbidity of chronic pain in the German general population. J Psychiatr Res. 2012;46(4):444–450. doi:10.1016/j.jpsychires.2012.01.001
   PubMed Web of Science ®Google Scholar
• Reid KJ, Harker J, Bala MM, et al. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011;27(2):449–462. doi:10.1185/03007995.2010.545813
   PubMed Web of Science ®Google Scholar
• Reitsma ML, Tranmer JE, Buchanan DM, Vandenkerkhof EG. The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008. Chronic Dis Inj Can. 2011;31(4):157–164.
   PubMedGoogle Scholar
• Tsang A, Von Korff M, Lee S, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–891. doi:10.1016/j.jpain.2008.05.005
   PubMed Web of Science ®Google Scholar
• Friessem CH, Willweber-Strumpf A, Zenz MW. Chronic pain in primary care. German figures from 1991 and 2006. BMC Public Health. 2009;9(1):299. doi:10.1186/1471-2458-9-299
   Web of Science ®Google Scholar
• Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain. 2002;6(5):375–385. doi:10.1016/S1090-3801(02)00025-3
   PubMed Web of Science ®Google Scholar
• Hensler S, Heinemann D, Becker MT, et al. Chronic pain in German general practice. Pain Med. 2009;10(8):1408–1415. doi:10.1111/j.1526-4637.2009.00735.x
   PubMed Web of Science ®Google Scholar
• Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010;11(1):144. doi:10.1186/1471-2474-11-144
   PubMed Web of Science ®Google Scholar
• Lalonde L, Choinieère M, Martin E, Berbiche D, Perreault S, Lussier D. Costs of moderate to severe chronic pain in primary care patients – a study of the ACCORD program. J Pain Res. 2014;7:389–403. doi:10.2147/JPR.S55388
   Web of Science ®Google Scholar
• Mills S, Torrance N, Smith BH. Identification and management of chronic pain in primary care: a review. Curr Psychiatry Rep. 2016;18(2):22. doi:10.1007/s11920-015-0659-9
   PubMed Web of Science ®Google Scholar
• Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the space randomized clinical trial. JAMA. 2018;319(9):872–882. doi:10.1001/jama.2018.0899
   PubMed Web of Science ®Google Scholar
• Argoff CE, Albrecht P, Irving G, Rice F. Multimodal analgesia for chronic pain: rationale and future directions. Pain Med. 2009;10(Suppl 2):S53–S66. doi:10.1111/j.1526-4637.2009.00669.x
   PubMed Web of Science ®Google Scholar
• Casale R, Symeonidou Z, Bartolo M. Topical treatments for localized neuropathic pain. Curr Pain Headache Rep. 2017;21(3):15. doi:10.1007/s11916-017-0615-y
   PubMed Web of Science ®Google Scholar
• Flores MP, Castro AP, Nascimento Jdos S. Topical analgesics. Rev Bras Anestesiol. 2012;62(2):244–252. doi:10.1016/S0034-7094(12)70122-8
   PubMed Web of Science ®Google Scholar
• Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Med. 2010;11(4):535–549. doi:10.1111/j.1526-4637.2010.00809.x
   PubMed Web of Science ®Google Scholar
• McCarberg BH, D’Arcy Y. Target pain with topical peripheral analgesics. Nurse Pract. 2007;32(7):44–49. doi:10.1097/01.NPR.0000279572.01195.84
   PubMedGoogle Scholar
• Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55(1):1–20. doi:10.1124/pr.55.1.1
   PubMed Web of Science ®Google Scholar
• Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333. doi:10.1016/j.ejpain.2005.06.009
   PubMed Web of Science ®Google Scholar
• Breivik H. A major challenge for a generous welfare system: a heavy socio-economic burden of chronic pain conditions in Sweden – and how to meet this challenge. Eur J Pain. 2012;16(2):167–169. doi:10.1002/j.1532-2149.2011.00025.x
   Web of Science ®Google Scholar
• Mäntyselkä PT, Turunen JH, Ahonen RS, Kumpusalo EA. Chronic pain and poor self-rated health. JAMA. 2003;290(18):2435–2442. doi:10.1001/jama.290.18.2435
   PubMed Web of Science ®Google Scholar
• Torrance N, Elliott AM, Lee AJ, Smith BH. Severe chronic pain is associated with increased 10-year mortality. A cohort record linkage study. Eur J Pain. 2010;14(4):380–386. doi:10.1016/j.ejpain.2009.07.006
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi:10.1016/j.jpain.2007.09.005
   PubMed Web of Science ®Google Scholar
• Jackman RP, Purvis JM, Mallett BS. Chronic nonmalignant pain in primary care. Am Fam Physician. 2008;78(10):1155–1162.
   PubMed Web of Science ®Google Scholar
• Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120(11):3760–3772. doi:10.1172/JCI42843
   PubMed Web of Science ®Google Scholar
• Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013;125(4 suppl 1):7–18. doi:10.1080/00325481.2013.1110566911
   PubMedGoogle Scholar
• Kendroud S, Hanna A. Physiology, nociceptive pathways. [Updated 2019 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Cline AE, Turrentine JE. Compounded topical analgesics for chronic pain. Dermatitis. 2016;27(5):263–271. doi:10.1097/DER.0000000000000216
   PubMed Web of Science ®Google Scholar
• Peppin JF, Albrecht PJ, Argoff C, et al. Skin matters: a review of topical treatments for chronic pain. Part one: skin physiology and delivery systems. Pain Ther. 2015;4(1):17–32. doi:10.1007/s40122-015-0031-0
   PubMed Web of Science ®Google Scholar
• Peppin JF, Albrecht PJ, Argoff C, et al. Skin matters: a review of topical treatments for chronic pain. Part two: treatments and applications. Pain Ther. 2015;4(1):33–50. doi:10.1007/s40122-015-0032-z
   PubMed Web of Science ®Google Scholar
• Gudin JA, Brennan MJ, Harris ED, et al. Changes in pain and concurrent pain medication following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational optimizing patient experience and response to topical analgesics study. J Pain Res. 2017;Volume 10(10):2341–2354. doi:10.2147/JPR.S143513
   Web of Science ®Google Scholar
• Gudin JA, Brennan MJ, Harris ED, et al. Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis. Postgrad Med. 2018;130(1):42–51. doi:10.1080/00325481.2018.1414551
   PubMed Web of Science ®Google Scholar
• Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013;125(4 Suppl 1):7–18.
   PubMedGoogle Scholar
• Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci. 2005;25(39):8924–8937. doi:10.1523/jneurosci.2574-05.2005.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Clin Ther. 2010;32(1):34–43. doi:10.1016/j.clinthera.2010.01.016.
   Web of Science ®Google Scholar
• Amman R, Peskar BA. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol. 2002;447(1):1–9. doi:10.1016/S0014-2999(02)01828-9
   Web of Science ®Google Scholar
• Mendoza TR, Chen C, Brugger A, et al. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain. 2004;20(5):357–362. doi:10.1097/00002508-200409000-00011
   Web of Science ®Google Scholar
• Erdemoglu AK, Koc R. Brief pain inventory score identifying and discriminating neuropathic and nociceptive pain. Acta Neurol Scand. 2013;128(5):351–358. doi:10.1111/ane.12131
   PubMed Web of Science ®Google Scholar
• Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309–318. doi:10.1097/00002508-200409000-00005
   PubMed Web of Science ®Google Scholar
• Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified brief pain inventory short form in patients with osteoarthritis. Eur J Pain. 2006;10(4):353–361. doi:10.1016/j.ejpain.2005.06.002
   PubMed Web of Science ®Google Scholar
• Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the brief pain inventory for chronic nonmalignant pain. J Pain. 2004;5(2):133–137. doi:10.1016/j.jpain.2003.12.005
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. PAIN. 2001;94(2):149–158. doi:10.1016/S0304-3959(01)00349-9
   PubMed Web of Science ®Google Scholar
• Kvien TK, Heiberg T, Hagen KB. Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? Ann Rheum Dis. 2007;66(Suppl 3):iii40–41. doi:10.1136/ard.2007.079798
   PubMed Web of Science ®Google Scholar
• Tubach F, Ravaud P, Martin-Mola E, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res (Hoboken). 2012;64(11):1699–1707. doi:10.1002/acr.21747
   PubMed Web of Science ®Google Scholar
• Upton FHR 6—21st century cures act. 114th congress (2015–2016) Jul 13, 2015. Available from: www.congress.gov/bill/114th-congress/house-bill/6/text. Accessed January 16, 2018.
   Google Scholar
• Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2020. Available at http://wonder.cdc.gov. Accessed June 20, 2020.
   Google Scholar
• Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse or opioid analgesics from 2004 to 2011. Pain Med. 2015;16(9):1745–1758. doi:10.1111/pme.12773
   Web of Science ®Google Scholar
• Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009;103(9):1227–1237. doi:10.1016/j.amjcard.2009.01.014
   PubMed Web of Science ®Google Scholar
• Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009;8(6):669–681. doi:10.1517/14740330903311023
   PubMed Web of Science ®Google Scholar
• John R, Herzenberg AM. Renal toxicity of therapeutic drugs. J Clin Pathol. 2009;62(6):505–515. doi:10.1136/jcp.2008.058271
   Web of Science ®Google Scholar
• Lazzaroni M, Porro GB. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors. Drugs. 2009;69(1):51–69. doi:10.2165/00003495-200969010-00004
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Hunt RH. Nonsteroidal anti-inflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am. 2010;39(3):433–464. doi:10.1016/j.gtc.2010.08.010
   PubMed Web of Science ®Google Scholar
• Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086. doi:10.1136/bmj.c7086
   PubMed Web of Science ®Google Scholar